Assessment Status | Rapid Review Complete |
HTA ID | 23002 |
Drug | Lutetium (177Lu) vipivotide tetraxetan |
Brand | Pluvicto® |
Assessment Process | |
Rapid review commissioned | 09/01/2023 |
Rapid review completed | 10/02/2023 |
Rapid review outcome | A full HTA is recommended to assess the clinical effectiveness and cost effectiveness of Lutetium (177Lu) vipivotide tetraxetan (Pluvicto®) compared with the current standard of care. |